421 related articles for article (PubMed ID: 33008796)
1. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
Hu T; Wolfram J; Srivastava S
Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
[TBL] [Abstract][Full Text] [Related]
2. Refining Cancer Management Using Integrated Liquid Biopsy.
Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
4. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
5. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
6. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
[TBL] [Abstract][Full Text] [Related]
7. Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles.
Špilak A; Brachner A; Kegler U; Neuhaus W; Noehammer C
Adv Drug Deliv Rev; 2021 Aug; 175():113819. PubMed ID: 34087328
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection.
Fiala C; Diamandis EP
Clin Chem Lab Med; 2020 Sep; 58(10):1651-1653. PubMed ID: 32160156
[TBL] [Abstract][Full Text] [Related]
9. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
[No Abstract] [Full Text] [Related]
10. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood.
Notarangelo M; Zucal C; Modelska A; Pesce I; Scarduelli G; Potrich C; Lunelli L; Pederzolli C; Pavan P; la Marca G; Pasini L; Ulivi P; Beltran H; Demichelis F; Provenzani A; Quattrone A; D'Agostino VG
EBioMedicine; 2019 May; 43():114-126. PubMed ID: 31047861
[TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy Technique May Allow Early Screening.
Cancer Discov; 2017 Nov; 7(11):1207. PubMed ID: 28903989
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy for cancer screening, diagnosis, and treatment.
Smania MA
J Am Assoc Nurse Pract; 2020 Jan; 32(1):5-7. PubMed ID: 31913212
[TBL] [Abstract][Full Text] [Related]
14. The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer.
Roy D; Pascher A; Juratli MA; Sporn JC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070509
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
Chen X; Wang L; Lou J
Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
[TBL] [Abstract][Full Text] [Related]
16. Potential of circulating biomarkers in liquid biopsy diagnostics.
Yeo JC; Lim CT
Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
[No Abstract] [Full Text] [Related]
17. Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation detection in early-stage non-small-cell lung cancer.
Wan Y; Liu B; Lei H; Zhang B; Wang Y; Huang H; Chen S; Feng Y; Zhu L; Gu Y; Zhang Q; Ma H; Zheng SY
Ann Oncol; 2018 Dec; 29(12):2379-2383. PubMed ID: 30339193
[TBL] [Abstract][Full Text] [Related]
18. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
Li D; Lai W; Fan D; Fang Q
Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
Zheng X; Li X; Wang X
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
[TBL] [Abstract][Full Text] [Related]
20. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
